Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In practice, the classification of scleroderma is less problematic than that of most other connective tissue diseases given the distinctive pattern of skin involvement. Classification of early and limited disease is more problematic and is difficult to separate from severe forms of Raynaud's phenomenon. Division of scleroderma into two groups depending on the presence or absence, early in the disease, of truncal skin involvement makes biological and clinical sense. Measurement using a clinical skin score remains the best approach to monitoring disease progress.

Original publication

DOI

10.1016/s0950-3579(05)80253-5

Type

Journal article

Journal

Bailliere's clinical rheumatology

Publication Date

08/1995

Volume

9

Pages

471 - 482

Addresses

ARC Epidemiology Research Unit, University of Manchester Medical School, UK.

Keywords

Humans, Scleroderma, Localized, Scleroderma, Systemic